Purple Biotech Ltd..
PPBT.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Purple Biotech Ltd., formerly Kitov Pharma Ltd., is a clinical-stage company focused on the development of oncology drugs. Their lead product candidate, CM24, is a monoclonal antibody targeting CEACAM5, currently in clinical trials for various solid tumors. They also have other preclinical programs ...Show More
Better Health for All
0
No evidence available to assess Purple Biotech Ltd. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess Purple Biotech Ltd. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
As of December 31, 2024, the company had 9 employees.
1
There is no public record of labor-law or human-rights violations.
2
No specific data is available regarding median employee pay, collective bargaining agreements, occupational injury rates, pay equity ratios, employee engagement scores, insecure contract share, or health insurance coverage.
3
While the CEO's compensation was $571,500 in 2024, the absence of median employee compensation data prevents the calculation of the CEO-to-median pay ratio.
4
The company's Code of Ethics outlines ethical conduct but does not provide quantitative data or outcomes related to worker welfare.
5
Fair Trade & Ethical Sourcing
0
No evidence available to assess Purple Biotech Ltd. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
-40
Purple Biotech Ltd. has a formal whistleblower protection policy that encourages reporting of violations without reprisal, allowing for anonymous and confidential submissions to superiors or the Audit Committee Chairman, and mentions protection from retaliation.
1
However, there is no evidence of independent investigation processes. The company also has an anti-corruption and anti-bribery policy that explicitly prohibits bribery, kickbacks, and payments to influence business, including direct and indirect payments, and provides guidelines for gifts and favors.
2
This policy is FCPA-compliant, but there is no evidence regarding the frequency or effectiveness metrics of its training.
Kind to Animals
0
No specific, concrete evidence was found in the provided articles regarding Purple Biotech Ltd.'s (PPBT.US) performance on any of the 'Kind to Animals' KPIs. The articles discuss general industry trends, regulatory changes, and alternative testing methods in the pharmaceutical sector, but do not provide any factual data, policies, or actions directly attributable to PPBT.US concerning animal welfare, testing, or sourcing. Therefore, all KPIs are omitted due to lack of company-specific evidence.
No War, No Weapons
0
Purple Biotech Ltd. is a pharmaceutical company focused on oncology drugs. The provided articles consistently state that the company is not a defense contractor and has no involvement in arms or defense-related activities. Therefore, its revenue from arms contracts is 0%.
1
It does not develop or sell dual-use technology.
2
And it has no sales to embargoed regimes.
3
The company's board oversight is focused on pharmaceutical development.
4
And it has no exposure to controversial weapons.
5
There are no defense-related assets to divest.
6
No ethical red lines related to weapons are needed.
7
And no peace technology investment ratio is applicable as it is not involved in military technology.
8
Planet-Friendly Business
-40
Purple Biotech Ltd. has no mention of SBTi-validated carbon reduction targets.
1
The company also shows poor performance in Reduced Greenhouse Gas Emissions (35.7) according to an ESG summary.
2
Respect for Cultures & Communities
0
The provided articles do not contain specific data or information regarding Purple Biotech Ltd.'s (PPBT.US) respect for cultures and communities. Details on formal partnerships, community investments, cultural incident protocols, local employment, or grievance mechanisms for PPBT.US are absent.
1
The available content focuses on the company's clinical-stage oncology therapies and general biotech industry diversity trends, without specific details on PPBT.US's community engagement or cultural impact.
Safe & Smart Tech
0
No specific, concrete data points were found in the provided articles for any of the 'Safe & Smart Tech' KPIs. The articles mention general cybersecurity risks and the company's subjection to FDA and cGMP regulations, but do not provide evidence regarding data breaches, AI ethics governance, cybersecurity investment, privacy certifications, security training effectiveness, encryption implementation, AI audit practices, algorithmic transparency, unauthorized data use, user data control, authentication security, vulnerability management, bug bounty effectiveness, privacy by design, security testing coverage, data minimization, compliance with privacy regulations (like GDPR or CCPA), algorithmic harm remediation, or digital rights advocacy.
1
Zero Waste & Sustainable Products
0
No specific, concrete evidence was found in the provided articles for any of the KPIs related to Zero Waste & Sustainable Products for Purple Biotech Ltd. refers to 'PBT' as a material with recyclability and durability, but there is no explicit information linking this 'PBT' to Purple Biotech Ltd. (PPBT.US) or its specific products. The other articles discuss general industry challenges or are irrelevant marketing materials, providing no quantitative data or specific actions for the company.